Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Neurovirol. 2019 Apr 24;25(4):508–519. doi: 10.1007/s13365-019-00751-0

Figure 2. HIV activation in astrocytes.

Figure 2.

The same number of HIV latent (G−M+) U373.MG and U373.MG.Tat at day 30 post infection of VSVG-RGH were treated with PMA (7.5 nM), LPS (10 ng/ml), TNF-α (10 ng/ml), 5’-Aza (5 μM), or GSK126 (7.5 μM) for 4 days and analyzed by flow cytometry for active replicating cells (G+M+). Untreated cells were included as a control (Ctrl). The data were Mean ± SD of triplicates and representative of three independent experiments.